CEO: Gerald T. Proehl.
Revenue: $125.3 million in 2010; $172.5 million in 2009.
Net income/loss: Net loss of $18.5 million in 2010; net profit of $32.1 million in 2009.
No. of local employees: 339.
Headquarters: Carmel Valley.
Year founded: 1996.
Stock symbol and exchange: SNTS on Nasdaq.
Company description: A specialty biopharmaceutical company focused on acquiring, developing and commercializing drugs to treat patients under the care of physician specialists.